{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T11:02:05Z","timestamp":1789297325508,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,15]],"date-time":"2027-05-15T00:00:00Z","timestamp":1810339200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actbio.2026.04.026","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:40:00Z","timestamp":1776444000000},"page":"403-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2415-8518","authenticated-orcid":false,"given":"Luman","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-5749","authenticated-orcid":false,"given":"Mansi","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-502X","authenticated-orcid":false,"given":"Emad I.","family":"Wafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra K.","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8803-3602","authenticated-orcid":false,"given":"Kasturi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2510-6779","authenticated-orcid":false,"given":"Kathleen A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3943-3251","authenticated-orcid":false,"given":"Daniela","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce C.","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-6633","authenticated-orcid":false,"given":"Aliasger K.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-9452","authenticated-orcid":false,"given":"Michael J.","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-5353","authenticated-orcid":false,"given":"Balaji","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.04.026_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"Ca"},{"key":"10.1016\/j.actbio.2026.04.026_bib0002","first-page":"1","article-title":"Chemotherapy in pancreatic cancer: a systematic review","volume":"54","author":"Hajatdoost","year":"2018","journal-title":"Medicina (Lithuania)"},{"key":"10.1016\/j.actbio.2026.04.026_bib0003","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.64805","article-title":"Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2026.04.026_bib0004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/(SICI)1097-0029(19970601)37:5\/6<456::AID-JEMT9>3.0.CO;2-B","article-title":"Lymphatic system of the pancreas","volume":"37","author":"O\u2019Morchoe","year":"1997","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.actbio.2026.04.026_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.04.026_bib0007","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMp1709968","article-title":"First FDA approval agnostic of cancer site-when a biomarker defines the indication","volume":"377","author":"Lemery","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.04.026_bib0008","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1158\/1078-0432.CCR-18-2992","article-title":"Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic adenocarcinoma (ECLIPSE study)","volume":"25","author":"Le","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.04.026_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0011","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1073\/pnas.96.6.2976","article-title":"Functional differences between memory and naive CD8 T cells","volume":"96","author":"Cho","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.04.026_bib0012","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrc3420","article-title":"Identifying people at a high risk of developing pancreatic cancer","volume":"13","author":"Klein","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2026.04.026_bib0013","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ijms20030561","article-title":"Genomic features and clinical management of patients with hereditary pancreatic cancer syndromes and familial pancreatic cancer","volume":"20","author":"Ohmoto","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.04.026_bib0014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.seminoncol.2007.05.005","article-title":"Detecting early pancreatic cancer: problems and prospects","volume":"34","author":"Chari","year":"2007","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2017.12.012","article-title":"Emerging trends in the immunotherapy of pancreatic cancer","volume":"417","author":"Banerjee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2026.04.026_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101298","article-title":"Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer","volume":"15","author":"Lin","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0018","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14728222.2017.1323880","article-title":"MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma","volume":"21","author":"Gautam","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.actbio.2026.04.026_bib0019","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","article-title":"Mucins in pancreatic cancer and its microenvironment","volume":"10","author":"Kaur","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0020","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/MPA.0b013e3182965915","article-title":"Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas","volume":"42","author":"Kitazono","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.actbio.2026.04.026_bib0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4049\/jimmunol.1000492","article-title":"Early signals during CD8+ T cell priming regulate the generation of central memory cells","volume":"185","author":"Obar","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0022","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1073\/pnas.93.18.9716","article-title":"On the role of antigen in maintaining cytotoxic T-cell memory","volume":"93","author":"K\u00fcndig","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.04.026_bib0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0024","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2021.03.037","article-title":"Engineering a sustained release vaccine with a pathogen-mimicking manner for robust and durable immune responses","volume":"333","author":"Hou","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.04.026_bib0025","doi-asserted-by":"crossref","first-page":"54399","DOI":"10.1021\/acsami.0c15522","article-title":"Employing ATP as a new adjuvant promotes the induction of robust antitumor cellular immunity by a PLGA nanoparticle vaccine","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2026.04.026_bib0026","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1021\/acsnano.9b05974","article-title":"Nanoscale coordination polymer based nanovaccine for Tumor immunotherapy","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.04.026_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep00198","article-title":"Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants","volume":"1","author":"Ulery","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.026_bib0028","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3389\/fimmu.2018.01953","article-title":"Polyanhydride nanovaccine induces robust pulmonary B and T cell immunity and confers protection against homologous and heterologous Influenza A virus infections","volume":"9","author":"Zacharias","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0029","first-page":"171","article-title":"Polyanhydride nanovaccine platform enhances antigen-specific cytotoxic T cell responses","volume":"02","author":"Huntimer","year":"2014","journal-title":"Technology (Singap. World. Sci)."},{"key":"10.1016\/j.actbio.2026.04.026_bib0030","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1016\/j.actbio.2012.11.001","article-title":"Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles","volume":"9","author":"Joshi","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.026_bib0031","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.2147\/IJN.S261041","article-title":"Polyanhydride nanoparticles induce low inflammatory dendritic cell activation resulting in CD8+ T cell memory and delayed tumor progression","volume":"15","author":"Darling","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.actbio.2026.04.026_bib0032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.actbio.2017.01.005","article-title":"The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response","volume":"50","author":"Wafa","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.026_bib0033","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.vaccine.2019.04.004","article-title":"STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice","volume":"37","author":"Darling","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2026.04.026_bib0034","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/acs.bioconjchem.0c00347","article-title":"Biotinylated streptavidin surface coating improves the efficacy of a PLGA microparticle-based cancer vaccine","volume":"31","author":"Gross","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2026.04.026_bib0035","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.vaccine.2013.07.055","article-title":"Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2026.04.026_bib0036","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cbic.201402689","article-title":"Antibody induction directed against the tumor-associated MUC4 glycoprotein","volume":"16","author":"Cai","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.actbio.2026.04.026_bib0037","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18632\/genesandcancer.189","article-title":"Amphiphilic polyanhydride-based recombinant MUC4\u03b2-nanovaccine activates dendritic cells","volume":"10","author":"Banerjee","year":"2019","journal-title":"Genes Cancer"},{"key":"10.1016\/j.actbio.2026.04.026_bib0038","article-title":"Biomaterial nanocarrier-driven mechanisms to modulate anti-tumor immunity","volume":"20","author":"Liu","year":"2021","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.actbio.2026.04.026_bib0039","first-page":"1","article-title":"Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4\u03b2","author":"Liu","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2026.04.026_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0023344","article-title":"Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer","volume":"6","author":"Jain","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2026.04.026_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101391","article-title":"MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy","volume":"47","author":"Gautam","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-024-01388-3","article-title":"Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients","volume":"16","author":"Zhang","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/j.actbio.2026.04.026_bib0043","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1158\/1078-0432.CCR-19-2881","article-title":"A pan-cancer clinical study of personalized neoantigen vaccine monotherapy in treating patients with various types of advanced solid tumors","volume":"26","author":"Fang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080580","article-title":"Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy","volume":"8","author":"Torres","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2026.04.026_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jbm.a.30510","article-title":"Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms","volume":"76","author":"Torres","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2026.04.026_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-02860-5","article-title":"Characterization of recombinant \u03b2 subunit of human MUC4 mucin (rMUC4\u03b2)","volume":"11","author":"Kshirsagar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.026_bib0047","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/S0142-9612(02)00181-3","article-title":"Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery","volume":"23","author":"Kipper","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.04.026_bib0048","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/mp2004059","article-title":"Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen","volume":"9","author":"Petersen","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2026.04.026_bib0049","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-4939-6445-1_14","article-title":"Production of adjuvant-loaded biodegradable particles for use in cancer vaccines","volume":"1494","author":"de Barros","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0050","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.4049\/jimmunol.163.8.4413","article-title":"Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides","volume":"163","author":"De Silva","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0051","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0161-5890(94)90155-4","article-title":"Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity","volume":"31","author":"Feltkamp","year":"1994","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0052","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0092-8674(90)90020-F","article-title":"Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro","volume":"62","author":"Schumacher","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2026.04.026_bib0053","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/350703a0","article-title":"Peptide selection by MHC class I molecules","volume":"350","author":"Schumacher","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.04.026_bib0054","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-3659(98)00191-6","article-title":"Determining the absolute surface hydrophobicity of microparticulates using thin layer wicking","volume":"59","author":"Norris","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.04.026_bib0055","article-title":"Enhanced fluorescent intensity of magnetic-fluorescent bifunctional PLGA microspheres based on Janus electrospraying for bioapplication","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.026_bib0056","author":"Steinbuck"},{"key":"10.1016\/j.actbio.2026.04.026_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00781-0","article-title":"Co-adjuvanting DDA\/TDB liposomes with a TLR7 agonist allows for IgG2a\/c class-switching in the absence of Th1 cells","volume":"8","author":"Zimmermann","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.actbio.2026.04.026_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105317","article-title":"T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study","volume":"108","author":"Wolf","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.actbio.2026.04.026_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214367","article-title":"Durable CD8 T cell memory against SARS-CoV-2 by prime\/boost and multi-dose vaccination: considerations on inter-dose time intervals","volume":"23","author":"Natalini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.04.026_bib0060","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1158\/0008-5472.CAN-03-2636","article-title":"Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis","volume":"64","author":"Singh","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0061","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1541-7786.MCR-06-0353","article-title":"MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins","volume":"5","author":"Chaturvedi","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0164-y","article-title":"A single dose polyanhydride-based nanovaccine against paratuberculosis infection","volume":"5","author":"Thukral","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.actbio.2026.04.026_bib0063","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/jbm.a.37080","article-title":"Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4\u03b2","volume":"109","author":"Liu","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2026.04.026_bib0064","first-page":"1","article-title":"Pathogen-specific T cell polyfunctionality is a correlate of T cell efficacy and immune protection","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2026.04.026_bib0065","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cancers13040821","article-title":"A palette of cytokines to measure anti-tumor efficacy of T cell-based therapeutics","volume":"13","author":"Ramesh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.actbio.2026.04.026_bib0066","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1648170","article-title":"Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile","volume":"8","author":"De Groot","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.actbio.2026.04.026_bib0067","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/cas.14420","article-title":"CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor","volume":"111","author":"Imai","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.actbio.2026.04.026_bib0068","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1158\/1078-0432.CCR-16-1692","article-title":"PD-1\u00fe polyfunctional T cells dominate the periphery after tumor-infiltrating lymphocyte therapy for cancer","volume":"23","author":"Donia","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0069","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2011-12-398321","article-title":"Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy","volume":"120","author":"Ding","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2026.04.026_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2015.12.018","article-title":"Clonal abundance of tumor-specific CD4+ T cells potentiates efficacy and alters susceptibility to exhaustion","volume":"44","author":"Malandro","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.actbio.2026.04.026_bib0071","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0072","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12274-019-2301-3","article-title":"Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration","volume":"12","author":"Howard","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0073","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/adhm.201200181","article-title":"Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery","volume":"2","author":"Huntimer","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2026.04.026_bib0074","first-page":"2213","article-title":"Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery","volume":"8","author":"Petersen","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2026.04.026_bib0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/138620709788923764","article-title":"High throughput cell-based screening of biodegradable polyanhydride libraries","volume":"12","author":"Adler","year":"2009","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.actbio.2026.04.026_bib0076","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/acsbiomaterials.0c01429","article-title":"Titrating polyarginine into nanofibers enhances cyclic-dinucleotide adjuvanticity in vitro and after sublingual immunization","volume":"7","author":"Kelly","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.actbio.2026.04.026_bib0077","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-023-00332-0","article-title":"Just right\u201d combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation","volume":"20","author":"Ananya","year":"2023","journal-title":"Immunity and Ageing"},{"key":"10.1016\/j.actbio.2026.04.026_bib0078","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-023-00349-5","article-title":"Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines","volume":"20","author":"Ross","year":"2023","journal-title":"Immunity and Ageing"},{"key":"10.1016\/j.actbio.2026.04.026_bib0079","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.actbio.2011.03.023","article-title":"Polyanhydride microparticles enhance dendritic cell antigen presentation and activation","volume":"7","author":"Torres","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.026_bib0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","article-title":"Polymer chemistry influences monocytic uptake of polyanhydride nanospheres","volume":"26","author":"Ulery","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2026.04.026_bib0081","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1166\/jbn.2016.2259","article-title":"Cellular internalization mechanisms of polyanhydride particles: implications for rational design of drug delivery vehicles","volume":"12","author":"Phanse","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.actbio.2026.04.026_bib0082","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1016\/j.biomaterials.2011.05.063","article-title":"Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants","volume":"32","author":"Petersen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.04.026_bib0083","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.actbio.2012.06.001","article-title":"Chemistry-dependent adsorption of serum proteins onto polyanhydride microparticles differentially influences dendritic cell uptake and activation","volume":"8","author":"Carrillo-Conde","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.026_bib0084","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2217\/imt.14.97","article-title":"A promising CpG adjuvant-loaded nanoparticle-based vaccine for treatment of dust mite allergies","volume":"6","author":"Salem","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.actbio.2026.04.026_bib0085","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.1117194109","article-title":"Polyfunctional responses by human T cells result from sequential release of cytokines","volume":"109","author":"Han","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.04.026_bib0086","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:06:02Z","timestamp":1778893562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":86,"alternative-id":["S1742706126002461"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.026","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}